Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Leishmaniasis: early-phase trial registry
1 of 4 indexed Leishmaniasis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Leishmaniasis: 4 US clinical trials tracked, 1 recruiting.
Leishmaniasis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is U.S. Army Medical Research and Development Command, running 2 of these trials.
Enrollment posture brief
Registry condition leishmaniasis
OPEN 1 | RECR 25% | LATE 0 | EARLY 2 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Leishmaniasis lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Leishmaniasis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Leishmaniasis is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Diagnosis and Treatment of Leishmania Infections
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00344188
Sodium Stibogluconate Treatment of Leishmaniasis
U.S. Army Medical Research and Development Command
NCT00662012
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03641339
Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
U.S. Army Medical Research and Development Command
NCT00657618
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Leishmaniasis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Leishmaniasis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Leishmaniasis page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Leishmaniasis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- U.S. Army Medical Research and Development Command sponsors the most Leishmaniasis trials on record, review their full trial history before evaluating a specific study. See U.S. Army Medical Research and Development Command's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Leishmaniasis condition card totals 4 registered trials; most-linked intervention Sodium Stibogluconate (SSG); top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.